• $299.9M
    Market Cap
  • 310.36%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-23.7M
-31.11%
-34.4M
+1.94%
-33.8M
-3.56%
-35.0M
+74.95%
Depreciation and Amortization Expense
1.5M
+15.55%
1.3M
+36.32%
972,000
+8.97%
892,000
-23.70%
Total Operating Expenses
41.5M
-12.75%
47.6M
+4.82%
45.4M
+6.98%
42.5M
+50.04%
Operating Profit
-36.6M
-13.67%
-42.4M
+3.78%
-40.9M
+10.68%
-36.9M
+55.09%
Interest Income
388,000
-44.33%
697,000
+289.39%
179,000
+517.24%
29,000
+480.00%
Interest Expense
N/A
N/A
-6.7M
+155.14%
-2.6M
N/A
0
+100.00%
Interest Income and Expense and Net
388,000
+106.46%
-6.0M
+145.32%
-2.4M
-8,537.93%
29,000
+149.15%
Total Nonoperating Income and Expense
-137.2M
-683.18%
23.5M
+183.54%
-28.2M
-97,186.21%
29,000
-95.65%
Income before Taxes
-36.6M
-13.67%
-42.4M
+3.78%
-40.9M
+10.68%
-36.9M
+55.09%
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-173.8M
+818.79%
-18.9M
-72.60%
-69.0M
+87.03%
-36.9M
+59.43%
Net Income from Continuing Operations Applicable to Common
-173.8M
+818.79%
-18.9M
-72.60%
-69.0M
+87.03%
-36.9M
+59.43%
Basic EPS and Net Income
-4.80
+823.08%
-0.52
-72.77%
-1.91
+76.85%
-1.08
+12.50%
Diluted EPS and Net Income
-4.80
+439.33%
-0.89
-53.40%
-1.91
+76.85%
-1.08
+12.50%
Basic Weighted Average Shares
36.2M
+0.22%
36.2M
+0.24%
36.1M
+5.19%
34.3M
+42.27%
Diluted Weighted Average Shares
36.2M
-38.64%
59.1M
+63.71%
36.1M
+5.19%
34.3M
+42.27%
Balance Sheet
Cash and Cash Equivalents
8.7M
-6.49%
9.3M
-31.29%
13.5M
-8.95%
14.9M
+44.36%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
8.7M
-6.49%
9.3M
-31.29%
13.5M
-8.95%
14.9M
+44.36%
Total Current Assets
10.7M
-5.66%
11.3M
-40.95%
19.2M
-29.19%
27.0M
+80.37%
Accumulated Depreciation
14.0M
+6.80%
13.1M
+11.21%
11.8M
+6.47%
11.1M
+8.59%
Property and Plant and Equipment and Net
12.2M
-7.91%
13.2M
+5.43%
12.6M
+247.22%
3.6M
+62.93%
Total Long-Term Assets
973,000
-0.21%
975,000
-60.53%
2.5M
+1.69%
2.4M
+38.40%
Total Assets
76.9M
-11.05%
86.4M
-12.12%
98.4M
+2.64%
95.8M
+37.36%
Income Taxes Payable
3.1M
0.00%
3.1M
0.00%
3.1M
0.00%
3.1M
0.00%
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
1.2M
0.00%
Total Current Liabilities
8.9M
-81.46%
48.2M
+193.11%
16.5M
-33.82%
24.9M
+416.68%
Total Long-Term Debt
256.9M
+363.46%
55.4M
-32.65%
82.3M
N/A
N/A
N/A
Total Long-Term Liabilities
32.7M
-3.43%
33.8M
-2.56%
34.7M
-8.49%
38.0M
-10.97%
Total Liabilities
295.5M
+119.76%
134.5M
+3.09%
130.4M
+118.27%
59.8M
+34.67%
Retained Earnings
-501.5M
+53.03%
-327.7M
+6.13%
-308.8M
+28.80%
-239.8M
+18.20%
Total Stockholders Equity
-218.6M
+355.23%
-48.0M
+49.76%
-32.1M
-188.87%
36.1M
+42.06%
Total Shares Outstanding
36.4M
+0.69%
36.2M
+0.17%
36.1M
-0.06%
36.1M
+33.31%
Cash Flow
Cash from Operating Activities
-25.8M
-31.39%
-37.6M
-20.82%
-47.4M
+46.00%
-32.5M
+37.78%
Capital Expenditures
542,000
-71.15%
1.9M
-76.93%
8.1M
+268.34%
2.2M
+69.56%
Cash from Investing Activities
-542,000
-71.15%
-1.9M
-76.90%
-8.1M
+267.89%
-2.2M
+69.56%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
25.6M
-26.73%
35.0M
-35.25%
54.0M
+22.66%
44.0M
+72.49%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-212.83%
+939.64%
-20.47%
-71.21%
-71.11%
+59.49%
-44.59%
+5.21%
Return on Equity
130.37%
+175.98%
47.24%
+101.37%
-3,439.35%
+2,763.74%
-120.10%
+14.77%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
1.19
+408.70%
0.23
-79.85%
1.16
+6.99%
1.09
-65.09%
Cash Ratio
0.97
+404.21%
0.19
-76.56%
0.82
+37.58%
0.60
-72.06%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow